PBI9 EVALUATION OF THE COST SAVING POTENTIAL OF INTRODUCING ADALIMUMAB BIOSIMILARS FOR THE TREATMENT OF ALL LICENSED ADULT ADALIMUMAB INDICATIONS IN IRELAND

Autor:	P. Aubrey, M. Waker, A. Levysohn, M. Bodin, S. Keady
Rok vydání:	2019
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 22:S48
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.04.092
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8a15a759274e9c20db637719c24faacb https://doi.org/10.1016/j.jval.2019.04.092 Zobrazit plný text záznamu Full Text from ScienceDirect